Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.88)
# 1,919
Out of 4,495 analysts
1233
Total ratings
52.4%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Hold | 1,900p → 1,950p | $1,972.00 | -1.12% | 166 | Jul 9, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 140.00 | $124.96 | +12.04% | 133 | Jul 7, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €750.00 → €900.00 | $793.40 | +13.44% | 33 | Jul 3, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | $13,132.00 | -12.43% | 187 | Jun 30, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 290.00 | $320.55 | -9.53% | 157 | Jun 19, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 → €95.00 | $76.40 | +24.35% | 143 | Jun 15, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Hold | $42 → $46 | $45.29 | +1.46% | 7 | Jun 4, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | $338.50 | +0.44% | 140 | May 27, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,400 → kr 2,250 | $1,888.98 | +19.11% | 23 | May 11, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $140 | $92.98 | +50.57% | 32 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 63.00 → CHF 70.00 | $68.38 | +2.37% | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.88 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | $250.17 | +17.92% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $909.49 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | $9.05 | +32.66% | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | $11.40 | +22.81% | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | kr 285.00 | $478.80 | n/a | 17 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | $26.70 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $43.90 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | $6.21 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $76.56 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,216.95 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $3.32 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.29 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | $165.30 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $52.02 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.78 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | $51.35 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $126 → $57 | $30.59 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $52.47 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.71 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | $49.99 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €62.90 → €78.00 | $140.85 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $154.62 | n/a | 4 | Dec 7, 2018 |
GSK plc
Jul 9, 2026
Maintained: Hold
Price Target: 1,900p → 1,950p
Current: $1,972.00
Upside: -1.12%
Novartis AG
Jul 7, 2026
Maintained: Buy
Price Target: CHF 140.00
Current: $124.96
Upside: +12.04%
argenx SE
Jul 3, 2026
Maintained: Buy
Price Target: €750.00 → €900.00
Current: $793.40
Upside: +13.44%
AstraZeneca PLC
Jun 30, 2026
Maintained: Sell
Price Target: 11,500p
Current: $13,132.00
Upside: -12.43%
Novo Nordisk A/S
Jun 19, 2026
Maintained: Hold
Price Target: kr 290.00
Current: $320.55
Upside: -9.53%
Sanofi
Jun 15, 2026
Maintained: Buy
Price Target: €100.00 → €95.00
Current: $76.40
Upside: +24.35%
Zealand Pharma A/S
Jun 4, 2026
Maintained: Hold
Price Target: $42 → $46
Current: $45.29
Upside: +1.46%
Roche Holding AG
May 27, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: $338.50
Upside: +0.44%
Genmab A/S
May 11, 2026
Maintained: Buy
Price Target: kr 2,400 → kr 2,250
Current: $1,888.98
Upside: +19.11%
BioNTech SE
Mar 17, 2026
Maintained: Buy
Price Target: $140
Current: $92.98
Upside: +50.57%
Feb 26, 2026
Downgraded: Hold
Price Target: CHF 63.00 → CHF 70.00
Current: $68.38
Upside: +2.37%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $48.88
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: $250.17
Upside: +17.92%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $909.49
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: $9.05
Upside: +32.66%
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: $11.40
Upside: +22.81%
Jul 8, 2025
Upgraded: Hold
Price Target: kr 285.00
Current: $478.80
Upside: n/a
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: $26.70
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $43.90
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: $6.21
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $76.56
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,216.95
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $3.32
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.29
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: $165.30
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $52.02
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $29.78
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: $51.35
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $126 → $57
Current: $30.59
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $52.47
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $17.71
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: $49.99
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €62.90 → €78.00
Current: $140.85
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $154.62
Upside: n/a